Consumers most worried about healthcare according to new survey

Healthcare costs are consumers' biggest worry, and just half have confidence in the healthcare system according to a recent survey. Consumer's latest survey focuses on the cost of living, and 68 per cent of...

Piramal buys Mallinckrodt LLC’s spasticity, pain-control drugs

Piramal Enterprises has kicked off the year with an acquisition by formalising a deal to buy UK-based Mallinckrodt LLC’s portfolio of intrathecal (administered via the spinal column) spasticity and pain-management drugs in an all-cash...

CureFit in talks to buy healthcare start-ups, including Serenity Mental Health

CureFit, a healthcare and fitness start-up launched by former Flipkart executives Mukesh Bansal and Ankit Nagori, is close to making two acquisitions as it prepares to launch its mobile app in the first half...
drug price

Call for drug price cuts no threat to ETF tracking U.S. biotech

Despite a call by U.S. President Donald Trump to cut drug price, there are no concerns about the outlook for an Exchange Traded Fund (ETF) that is listed on the local main board to...
Mckesson

McKesson acquires CoverMyMeds for $1.1 billion

McKesson has entered into a definitive agreement to acquire CoverMyMeds, a developer of electronic prior authorization technology, for $1.1 billion or $0.9 billion net of cash incremental cash benefits, the companies announced Jan. 25. The...

Many firms on back foot due to US regulatory woes

It has been a mixed bag in terms of performance of pharma stocks in the last one year. Jubilant Life, Biocon and Caplin Point Lab gave top returns; up by 118 per cent, 104...

Granules to invest $20 mn in US subsidiary, Q3 net up 34% at Rs....

The company Board of Granules India Ltd has announced its move to invest $20 million in its wholly-owned subsidiary Granules Pharmaceulticals Inc. The company registered a net profit of Rs. 39 crore during the third quarter ended...